We are live on
!
Find out more
Revolution Medicines Inc Warrant
RVMDW
RVMDW
Fund managers haven’t disclosed any holdings of RVMDW yet.
RVMDW Hedge Fund Activity: Q1 2026 in Review
23 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines Inc Warrant (RVMDW) for Q1 2026, worth a combined $18.1M — up 118% from $8.31M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of RVMDW and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 6 added.
The largest buyer was Sculptor Capital, adding an estimated $1.51M. The largest seller was Soros Capital Management, exiting entirely with an estimated $343K sold.
- 23 institutional investors held Revolution Medicines Inc Warrant (RVMDW) as of Q1 2026, down from 24 in Q4 2025.
- Funds reported $18.1M of Revolution Medicines Inc Warrant stock for Q1 2026, up 118% quarter-over-quarter.
- 2 funds opened new Revolution Medicines Inc Warrant positions in Q1 2026 and 3 closed out, a net change of -1 holder.
- The largest Revolution Medicines Inc Warrant buyer in Q1 2026 was Sculptor Capital, an estimated $1.51M added.
- The largest Revolution Medicines Inc Warrant seller in Q1 2026 was Soros Capital Management, an estimated $343K sold.
Based on aggregated 13F filings for Q1 2026.